The life science industry has seen rapid growth within our region in recent years, supported by expanding demand from Asia Pacific’s large and ageing population and supportive government policies. While global pharmaceutical giants from the U.S. and Europe still dominate the market, Asia Pacific based firms are expanding rapidly, which account for 28% of the global revenue in 2020.

In this episode of Talking Property, Henry Chin CBRE’s Global Head of Investor Thought Leadership sits down with Mark Coster Head of Capital Markets, Pacific and David Keenan National Director of Science & Research, Australia. Together, they explore the latest trends, demand drivers, corporate real estate strategies and investment opportunities in major life sciences hubs across the Pacific.

The full report can be found at https://apacresearch.cbre.com/en/research-and-reports